EQTEC (EQT) Competitors GBX 0.46 -0.04 (-7.04%) As of 11:28 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock EQT vs. MXC, HNR, SUN, NOG, WRES, VAL, CRC, WEB, NBL, and FTOShould you be buying EQTEC stock or one of its competitors? The main competitors of EQTEC include Argent BioPharma (MXC), Highlands Natural Resources (HNR), Surgical Innovations Group (SUN), Nostrum Oil & Gas (NOG), W Resources (WRES), ValiRx (VAL), Circle Property (CRC), Webis (WEB), 18564 (NBL.L) (NBL), and 2059984 (FTO.L) (FTO). These companies are all part of the "petroleum and natural gas" industry. EQTEC vs. Its Competitors Argent BioPharma Highlands Natural Resources Surgical Innovations Group Nostrum Oil & Gas W Resources ValiRx Circle Property Webis 18564 (NBL.L) 2059984 (FTO.L) EQTEC (LON:EQT) and Argent BioPharma (LON:MXC) are both small-cap petroleum and natural gas companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends. Is EQT or MXC more profitable? Argent BioPharma's return on equity of 0.00% beat EQTEC's return on equity.Company Net Margins Return on Equity Return on Assets EQTECN/A -83.34% -14.55% Argent BioPharma N/A N/A -58.96% Does the media prefer EQT or MXC? In the previous week, EQTEC's average media sentiment score of 0.00 equaled Argent BioPharma'saverage media sentiment score. Company Overall Sentiment EQTEC Neutral Argent BioPharma Neutral Do institutionals and insiders hold more shares of EQT or MXC? 0.1% of EQTEC shares are owned by institutional investors. Comparatively, 1.2% of Argent BioPharma shares are owned by institutional investors. 10.4% of EQTEC shares are owned by company insiders. Comparatively, 8.2% of Argent BioPharma shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has higher earnings and valuation, EQT or MXC? Argent BioPharma has lower revenue, but higher earnings than EQTEC. EQTEC is trading at a lower price-to-earnings ratio than Argent BioPharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEQTEC£2.20M1.34-£24.55M-£0.07-6.79Argent BioPharma£1.32M0.00-£17.02M-£1.66N/A Which has more volatility & risk, EQT or MXC? EQTEC has a beta of 2.07, indicating that its share price is 107% more volatile than the S&P 500. Comparatively, Argent BioPharma has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500. SummaryEQTEC beats Argent BioPharma on 6 of the 9 factors compared between the two stocks. Get EQTEC News Delivered to You Automatically Sign up to receive the latest news and ratings for EQT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EQT vs. The Competition Export to ExcelMetricEQTECSpecialty Industrial Machinery IndustryIndustrials SectorLON ExchangeMarket Cap£2.96M£7.09B£7.80B£2.60BDividend Yield1.83%2.75%4.59%5.30%P/E Ratio-6.79322.11303.064,396.30Price / Sales1.3414,707.311,311.37100,736.12Price / Cash2.859.3327.8527.90Price / Book0.062.934.888.07Net Income-£24.55M£298.37M£791.48M£5.89B7 Day Performance-7.60%-0.94%-0.82%-0.11%1 Month Performance4.76%3.67%3.75%2.21%1 Year Performance-44.00%19.46%28.52%145.00% EQTEC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EQTEQTECN/AGBX 0.46-7.0%N/A-39.8%£2.96M£2.20M-6.79740Gap DownMXCArgent BioPharmaN/AN/AN/AN/A£9.65M£1.32M-13.255Gap UpHNRHighlands Natural ResourcesN/AN/AN/AN/A£6.95M£1.02M-0.9616Gap DownHigh Trading VolumeSUNSurgical Innovations GroupN/AGBX 0.60+4.2%N/A-0.2%£5.59M£11.92M-383.9780Gap UpNOGNostrum Oil & Gas1.4075 of 5 starsGBX 3.20-9.6%GBX 4+25.0%-18.9%£5.28M£135.89M-2.3730Gap DownWRESW ResourcesN/AN/AN/AN/A£3.89M£3.47M-0.4366Gap DownVALValiRxN/AGBX 0.50-4.4%N/A-62.8%£1.88M£49.78K-53.985,450Gap DownCRCCircle PropertyN/AN/AN/AN/A£1.02M£7.57M50.001,060Gap DownHigh Trading VolumeWEBWebisN/AN/AN/AN/A£157K£49.70M14.1350Gap DownNBL18564 (NBL.L)N/AN/AN/AN/A£0.00N/A0.002,330FTO2059984 (FTO.L)N/AN/AN/AN/A£0.00N/A0.00147,000 Related Companies and Tools Related Companies Argent BioPharma Competitors Highlands Natural Resources Competitors Surgical Innovations Group Competitors Nostrum Oil & Gas Competitors W Resources Competitors ValiRx Competitors Circle Property Competitors Webis Competitors 18564 (NBL.L) Competitors 2059984 (FTO.L) Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:EQT) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EQTEC plc Please log in to your account or sign up in order to add this asset to your watchlist. Share EQTEC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
